Skip to main content
. Author manuscript; available in PMC: 2022 Jan 14.
Published in final edited form as: AAPS PharmSciTech. 2021 Jan 14;22(1):48. doi: 10.1208/s12249-020-01916-5

Figure 5:

Figure 5:

In vivo acyclovir concentrations obtained in cornea from ocular inserts and control solution at equivalent dose, 2 h and 4 h after topical application in conscious rabbit model. All experiments were performed in triplicate. *** Symbol represented indicates statistically significant difference in ocular inserts and control (p < 0.001).